Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.
ClinicalTrials.gov study NCT04460911. IPD Sharing: NO. Countries: 1. Publications: 0.
Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
ClinicalTrials.gov study NCT03304080. IPD Sharing: YES. Countries: 1. Publications: 0.
24-hr Intraocular Pressure Control With SIMBRINZA ®
ClinicalTrials.gov study NCT02770248. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis
ClinicalTrials.gov study NCT05153187. IPD Sharing: NO. Countries: 1. Publications: 0.
BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
ClinicalTrials.gov study NCT06253195. IPD Sharing: YES. Countries: 1. Publications: 0.
The MUSIC-HR Study
ClinicalTrials.gov study NCT04268433. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens
ClinicalTrials.gov study NCT02634190. IPD Sharing: NO. Countries: 0. Publications: 2.
A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC)
ClinicalTrials.gov study NCT04149574. IPD Sharing: Not stated. Countries: 16. Publications: 0.
RW Treatment Patterns and Outcomes in Postmenopausal HR+/HER2- mBC Patients Treated With Palbociclib Plus Letrozole as Initial Endocrine Therapy at Community Oncology Practices in the U.S.
ClinicalTrials.gov study NCT04460898. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT04031885. IPD Sharing: YES. Countries: 2. Publications: 0.
HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes
ClinicalTrials.gov study NCT04396626. IPD Sharing: NO. Countries: 1. Publications: 0.
Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer
ClinicalTrials.gov study NCT00570323. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
ClinicalTrials.gov study NCT06726148. IPD Sharing: YES. Countries: 14. Publications: 0.
A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stag
ClinicalTrials.gov study NCT06733233. IPD Sharing: YES. Countries: 0. Publications: 5.
ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT06970912. IPD Sharing: NO. Countries: 1. Publications: 0.
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
ClinicalTrials.gov study NCT07198724. IPD Sharing: YES. Countries: 1. Publications: 0.
Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.
ClinicalTrials.gov study NCT05155566. IPD Sharing: NO. Countries: 2. Publications: 0.
Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT04720664. IPD Sharing: NO. Countries: 1. Publications: 0.
HR Combined With FOLFOX4 for HCC With PVTT
ClinicalTrials.gov study NCT02452853. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Assessing Visual Feedback of HR Monitoring in Rehabilitation - Pilot
ClinicalTrials.gov study NCT05273801. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.